India’s Aurobindo Pharma Removed From U.S. FDA Import Alert
This article was originally published in PharmAsia News
Executive Summary
India’s Aurobindo Pharma Ltd. Shares of Aurobindo Pharma Ltd. was removed off the U.S. FDA import alert for one its manufacturing facilities in south India, helping its shares gain sharply.